Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Epididymal Cyst Removal — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-07-07
Ad — after-intro

Quick Facts

Procedure Type
Minor urological / day surgery
Anaesthesia
Local, regional, or general
Duration
30–60 minutes
Hospital Stay
Day case (outpatient)
Recovery Time
1–2 weeks to normal activity
Recurrence Rate
Less than 10% with complete excision
Fertility Impact
Low risk when performed carefully
Last Reviewed
2026-06-26
Reviewer
MyMedicPlus Medical Review Board

Treatment Overview

An epididymal cyst (also called a spermatocele when it contains fluid and dead sperm cells) is a benign, fluid-filled sac that develops within the epididymis — the coiled tube located at the back of each testicle responsible for sperm maturation and transport. These cysts are extremely common, detected incidentally in up to 30% of men undergoing scrotal ultrasound, and the vast majority cause no symptoms and require no intervention.

When a cyst becomes large enough to cause persistent discomfort, heaviness, or significant psychological distress, surgical removal — termed epididymal cystectomy or spermatocelectomy — is considered. The procedure involves careful dissection and excision of the cyst while preserving the surrounding epididymal tubules and vas deferens. It is typically performed as a day-case procedure under local, regional (spinal/epidural), or general anaesthesia, and most patients return to non-strenuous work within one week.

Modern microsurgical techniques have substantially improved outcomes by minimising trauma to adjacent structures. International centres of excellence — particularly in India, Thailand, and Turkey — offer this procedure at a fraction of Western prices, with comparable surgical standards and JCI-accredited facilities that attract thousands of medical tourists annually.

Conditions Treated

Epididymal cyst removal addresses a spectrum of benign scrotal cystic conditions, including:

  • Epididymal cysts: Thin-walled, clear fluid-filled sacs arising from the head, body, or tail of the epididymis — the most common benign scrotal mass
  • Spermatoceles: Cysts containing milky fluid with spermatozoa, typically arising from the epididymal head (caput epididymis)
  • Multiple or multiloculated epididymal cysts: Clusters of cysts causing progressive enlargement and discomfort
  • Painful or symptomatic cysts: Any epididymal cyst causing chronic scrotal pain, heaviness, or sexual dysfunction unresponsive to conservative measures
  • Large cysts with cosmetic concern: Cysts reaching several centimetres in diameter causing scrotal asymmetry or distress
Patients are selected for this procedure following thorough clinical assessment, diagnostic imaging, and where applicable pathological confirmation, ensuring that each case meets the evidence-based indications supported by current international clinical practice guidelines.

Who Is a Candidate

Ideal candidates for epididymal cyst removal include men who:

  • Have a confirmed epididymal cyst or spermatocele on ultrasound examination
  • Experience persistent scrotal pain, pressure, or discomfort not adequately controlled by analgesics or scrotal support
  • Have a cyst large enough (typically >2 cm) to interfere with daily activities, exercise, or sexual function
  • Have been monitored conservatively for 6–12 months with no resolution or further enlargement
  • Are sufficiently fit for surgery and anaesthesia

Contraindications and situations requiring caution include:

  • Desire for future fertility: Surgery carries a small but real risk of damage to the epididymis or vas deferens; men who have not yet completed their families should be carefully counselled
  • Bilateral cysts in young men: Bilateral epididymal surgery significantly increases fertility risk
  • Suspected malignancy: Any suspicious features on ultrasound (solid component, hypervascularity, irregular margins) necessitate testicular cancer workup before proceeding
  • Active scrotal infection: Surgery is deferred until infection resolves
  • Uncontrolled bleeding disorders or anticoagulation: Requires appropriate bridging and haematological optimisation
  • Asymptomatic small cysts: Watchful waiting is the preferred approach; surgery is not indicated

Treatment Options & Techniques

The management of epididymal cysts ranges from conservative surveillance to surgical excision, depending on symptom burden and cyst characteristics.

Conservative management (watchful waiting): Appropriate for asymptomatic or minimally symptomatic cysts. Scrotal support garments, non-steroidal anti-inflammatory drugs (NSAIDs), and periodic ultrasound monitoring every 12–24 months are recommended. The majority of cysts remain stable.

Aspiration and sclerotherapy: Ultrasound-guided needle aspiration empties the cyst but has a high recurrence rate (50–80%) because the cyst wall is not removed. Sclerotherapy (injection of a sclerosant such as polidocanol or tetracycline after aspiration) reduces recurrence to approximately 30–40% but is not universally recommended due to risks of epididymal fibrosis.

Surgical excision (epididymal cystectomy/spermatocelectomy): The definitive treatment. Performed through a small transverse hemiscrotal incision, the surgeon delivers the testis, isolates the cyst, and excises it with a thin rim of epididymal tissue. Microsurgical technique using loupe magnification (×3.5–×6) or the operating microscope allows precise dissection with minimal collateral damage. The testis is returned to the scrotum and the wound closed in layers. The procedure takes 30–60 minutes and is almost always performed as a day case.

Laparoscopic/robotic approach: Rarely used for uncomplicated epididymal cysts but may be considered for complex intra-abdominal variants or in centres with high robotic volume.

The selection of treatment approach follows a systematic assessment of clinical factors, patient preferences, and risk-benefit considerations. Evidence-based guidelines from professional societies including WHO, NICE, and relevant specialty organisations inform treatment selection and protocol design. Combination treatment strategies are increasingly favoured where multiple modalities provide synergistic benefit. The sequence and intensity of treatment components are titrated based on patient response at defined assessment intervals. Patients not responding adequately to initial treatment undergo structured reassessment to identify alternative approaches or combination strategies. Personalised medicine approaches using biomarker profiling and genetic analysis are emerging as tools to predict treatment response and guide individualised treatment selection in eligible patients. Multidisciplinary team review ensures all relevant clinical expertise informs treatment decisions for complex cases.

Benefits & Expected Outcomes

Surgical excision is highly effective and provides durable symptom relief for the majority of patients:

  • Symptom resolution: Over 90% of patients report complete or substantial relief of scrotal pain and discomfort following surgery
  • Low recurrence: Complete surgical excision with microsurgical technique achieves recurrence rates below 5–10%, significantly lower than aspiration alone
  • Short recovery: Most men return to desk work within 5–7 days and to physical labour or sport within 2–3 weeks
  • Minimal scarring: The hemiscrotal incision heals to a barely visible scar within the natural scrotal skin folds
  • Outpatient convenience: Day-case surgery avoids hospital admission, reducing costs and recovery time
  • Psychological benefit: Relief from anxiety associated with a persistent scrotal mass once malignancy has been excluded
Patient outcomes are optimised when surgery is performed by experienced specialists at high-volume accredited centres, where procedural volume correlates with reduced complication rates, shorter hospital stays, and superior long-term functional results compared to lower-volume institutions.

Risks & Complications

Epididymal cyst removal is a low-risk procedure, but patients should be informed of the following potential complications:

  • Haematoma (scrotal bruising/blood collection): Occurs in approximately 3–5% of cases; usually resolves spontaneously but may require surgical drainage if large
  • Wound infection: Reported in 1–2% of procedures; treated with antibiotics
  • Epididymal damage and infertility: Inadvertent injury to epididymal tubules can impair sperm transport; the risk is higher with large or densely adherent cysts and is the key reason to counsel men who desire future fertility
  • Recurrence: Incomplete excision or new cyst formation occurs in up to 10% of cases over long-term follow-up
  • Chronic scrotal pain: A small proportion of men (1–3%) develop post-surgical chronic pain, likely due to nerve entrapment or neuroma formation
  • Testicular atrophy: Rare complication from vascular compromise during dissection
  • Anaesthetic risks: Standard risks of local or general anaesthesia, minimised by pre-operative assessment

Recovery & Follow-Up

Immediate post-operative period (Days 1–3): Patients are discharged home on the day of surgery. Scrotal support (tight-fitting underwear or a jockstrap) is worn continuously for at least 1 week to minimise swelling. Ice packs applied intermittently during the first 24 hours help reduce oedema. Paracetamol and NSAIDs provide adequate analgesia for most patients.

First week: Swelling, bruising, and mild discomfort are expected. Light activities may resume after 2–3 days. Strenuous physical activity, heavy lifting, and sexual activity are restricted for 2 weeks. Non-dissolvable sutures (if used) are removed at 7–10 days.

Weeks 2–4: The majority of patients return to full normal activity including exercise and sexual intercourse. Residual scrotal firmness from healing may persist for 4–6 weeks and is normal.

Follow-up schedule:

  • Post-operative wound check at 1–2 weeks
  • Clinical review at 6 weeks to confirm resolution and assess fertility concerns if applicable
  • Ultrasound at 3–6 months if symptoms recur or a new mass is detected

Men who wished to preserve fertility should consider a semen analysis at 3 months post-operatively if they notice any change in ejaculatory function.

Cost Factors

The total cost of epididymal cyst removal varies depending on the country, hospital tier, anaesthesia type, and whether additional tests (e.g., pre-operative ultrasound, semen analysis) are included. Indicative ranges for the full surgical package are:

  • United States: USD 3,500–8,000 (outpatient surgical centre)
  • United Kingdom: GBP 1,800–4,500 (private hospital)
  • Australia: AUD 3,000–6,000
  • India: USD 600–1,200 — significant savings with JCI/NABH-accredited hospitals
  • Thailand: USD 900–1,800
  • Turkey: USD 700–1,400
  • Poland / Czech Republic: USD 800–1,600

Cost factors include surgeon's fee, anaesthesiologist fee, operating theatre charges, hospital facility fee, pre-operative investigations (blood tests, ultrasound), and post-operative follow-up consultations. Medical tourism packages from accredited hospitals often bundle these costs with airport transfers and patient coordination services.

International patients should factor in the cost of pre-operative testing, post-operative accommodation during recovery, translation services where required, and travel insurance including medical evacuation cover when planning overseas medical treatment.

Alternative Treatments

  • Watchful waiting: First-line recommendation for asymptomatic cysts; avoids all surgical risks with no loss of therapeutic window
  • Scrotal support and analgesics: Effective for mild discomfort; a trial of 3–6 months is appropriate before considering surgery
  • Ultrasound-guided aspiration: Simple outpatient procedure providing temporary relief; high recurrence rate (50–80%) limits its use to patients unfit for surgery
  • Sclerotherapy: Aspiration followed by injection of a sclerosing agent; lower recurrence than aspiration alone but increased risk of epididymal fibrosis; not widely recommended for men wishing to preserve fertility
Before proceeding with any surgical or procedural intervention, patients should discuss all available treatment options with their specialist to ensure that the chosen approach is the most appropriate for their specific clinical situation, preferences, and life circumstances.

Frequently Asked Questions

No. Epididymal cyst removal (spermatocelectomy) excises only the cyst from the epididymis and does not interrupt the vas deferens. Vasectomy deliberately cuts the vas deferens to prevent sperm from reaching semen. The two procedures are anatomically and functionally distinct.
There is a small risk. Microsurgical technique minimises damage to the epididymal tubules, but any scrotal surgery carries some risk of affecting sperm transport. Men who have not completed their family should discuss fertility-preserving options with their urologist and consider sperm banking before surgery.
Most patients return to light work within 5–7 days. Strenuous exercise and heavy lifting should be avoided for 2 weeks. Full recovery, including resolution of swelling and bruising, typically takes 4–6 weeks.
No. Epididymal cysts and spermatoceles are entirely benign lesions and do not transform into cancer. However, any new scrotal mass should be evaluated with ultrasound to exclude testicular cancer before being labelled a benign cyst.
Patients can typically save 60–80% by having the procedure in India, Thailand, or Turkey versus the UK or USA. A procedure costing USD 5,000–8,000 in the United States may cost USD 600–1,200 at a JCI-accredited hospital in India, including pre-operative tests and follow-up.

References

  1. Sharlip ID, et al. 'AUA Guideline on the Optimal Evaluation of the Infertile Male.' Journal of Urology, 2021; 205(Suppl 1):S1–S35.
  2. Ciftci AO, et al. 'Surgical Management of Epididymal Cysts: Outcomes and Long-Term Recurrence.' British Journal of Urology International, 2018; 121(4):603–608.
  3. Favorito LA, et al. 'Microsurgical Approach to Scrotal Pathology: Review of Outcomes.' International Brazilian Journal of Urology, 2020; 46(3):352–359.
  4. EAU Guidelines on Male Infertility. European Association of Urology, 2024 Edition.
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-07-07

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.